论文信息 - Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients - 字舞流文

Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients

P. Zoppoli | G. Viglietto | G. Botti | R. Franco | A. Rizzuto | C. de Marco | E. La Mantia | G. Rocco | F. Zito Marino | D. Malanga | D. Oliveira | C. Marinaro | Nicla de Rosa | M. Scrima | Donatella Malanga | Carmela de Marco